Literature DB >> 30943016

RNA-Guided Adenosine Deaminases: Advances and Challenges for Therapeutic RNA Editing.

Genghao Chen1, Dhruva Katrekar1, Prashant Mali1.   

Abstract

Targeted transcriptome engineering, in contrast to genome engineering, offers a complementary and potentially tunable and reversible strategy for cellular engineering. In this regard, adenosine to inosine (A-to-I) RNA base editing was recently engineered to make programmable base conversions on target RNAs. Similar to the DNA base editing technology, A-to-I RNA editing may offer an attractive alternative in a therapeutic setting, especially for the correction of point mutations. This Perspective introduces five currently characterized RNA editing systems and serves as a reader's guide for implementing an appropriate RNA editing strategy for applications in research or therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30943016     DOI: 10.1021/acs.biochem.9b00046

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.321


  9 in total

1.  Endogenous ADAR-mediated RNA editing in non-human primates using stereopure chemically modified oligonucleotides.

Authors:  Prashant Monian; Chikdu Shivalila; Genliang Lu; Mamoru Shimizu; David Boulay; Karley Bussow; Michael Byrne; Adam Bezigian; Arindom Chatterjee; David Chew; Jigar Desai; Frank Favaloro; Jack Godfrey; Andrew Hoss; Naoki Iwamoto; Tomomi Kawamoto; Jayakanthan Kumarasamy; Anthony Lamattina; Amber Lindsey; Fangjun Liu; Richard Looby; Subramanian Marappan; Jake Metterville; Ronelle Murphy; Jeff Rossi; Tom Pu; Bijay Bhattarai; Stephany Standley; Snehlata Tripathi; Hailin Yang; Yuan Yin; Hui Yu; Cong Zhou; Luciano H Apponi; Pachamuthu Kandasamy; Chandra Vargeese
Journal:  Nat Biotechnol       Date:  2022-03-07       Impact factor: 68.164

2.  Rational Design of RNA Editing Guide Strands: Cytidine Analogs at the Orphan Position.

Authors:  Erin E Doherty; Xander E Wilcox; Lenka van Sint Fiet; Cherie Kemmel; Janne J Turunen; Bart Klein; Dean J Tantillo; Andrew J Fisher; Peter A Beal
Journal:  J Am Chem Soc       Date:  2021-05-03       Impact factor: 15.419

Review 3.  Gene-based therapies for neurodegenerative diseases.

Authors:  Jichao Sun; Subhojit Roy
Journal:  Nat Neurosci       Date:  2021-02-01       Impact factor: 24.884

4.  Investigating REPAIRv2 as a Tool to Edit CFTR mRNA with Premature Stop Codons.

Authors:  Raffaella Melfi; Patrizia Cancemi; Roberta Chiavetta; Viviana Barra; Laura Lentini; Aldo Di Leonardo
Journal:  Int J Mol Sci       Date:  2020-07-06       Impact factor: 5.923

5.  Development of a Single Construct System for Site-Directed RNA Editing Using MS2-ADAR.

Authors:  Tetsuto Tohama; Matomo Sakari; Toshifumi Tsukahara
Journal:  Int J Mol Sci       Date:  2020-07-13       Impact factor: 5.923

6.  Learning cis-regulatory principles of ADAR-based RNA editing from CRISPR-mediated mutagenesis.

Authors:  Xin Liu; Tao Sun; Anna Shcherbina; Qin Li; Inga Jarmoskaite; Kalli Kappel; Gokul Ramaswami; Rhiju Das; Anshul Kundaje; Jin Billy Li
Journal:  Nat Commun       Date:  2021-04-12       Impact factor: 14.919

Review 7.  Novel Engineered Programmable Systems for ADAR-Mediated RNA Editing.

Authors:  Guillermo Aquino-Jarquin
Journal:  Mol Ther Nucleic Acids       Date:  2020-01-15       Impact factor: 8.886

8.  RNA editing of BFP, a point mutant of GFP, using artificial APOBEC1 deaminase to restore the genetic code.

Authors:  Sonali Bhakta; Matomo Sakari; Toshifumi Tsukahara
Journal:  Sci Rep       Date:  2020-10-14       Impact factor: 4.379

Review 9.  Site-directed RNA editing: recent advances and open challenges.

Authors:  Hamid Mansouri Khosravi; Michael F Jantsch
Journal:  RNA Biol       Date:  2021-09-27       Impact factor: 4.652

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.